MIND Diet

This page as PDF · Summary

1. What the MIND Diet Is

The MIND diet is not a food and not a preparation, but a dietary pattern. The name stands for Mediterranean-DASH Intervention for Neurodegenerative Delay: the pattern combines elements of the Mediterranean diet with elements of the DASH diet, which was developed for blood-pressure control, and additionally directs food choice toward items associated with brain ageing. What is examined is not the intake of individual substances but the proximity of actual diet to this pattern. The oldest works in the evaluation date from 2015, the most recent from 2026. A large part of the research comes from observational studies in which participants were followed over years and their diet was recorded at baseline or repeatedly.

For the understanding of all works it is crucial that a dietary pattern cannot be dosed. A point score for proximity to the recommended diet is recorded, and this score depends on how it was assessed. The endpoints are likewise diverse: cognitive test batteries, brain-structure imaging, metabolic and hormone values, inflammatory markers, sleep and psychological questionnaires. A 2021 study related circulating carotenoids to cognitive performance in MIND-study participants; a randomised 2025 study examined sleep status, mental health and serum BDNF levels in overweight diabetic women with insomnia. A marker value and a test value are therefore not the same, and two studies with different endpoints cannot be read directly against each other.

2. What the Studies Show in Detail

The supporting human studies and the most important reviews — by application area, with population, duration, preparation, measure and result as reported in the original works. Numbers appear only where the work states them.

Distribution of controlled human studies by application area — the numbers are not additive, as one study may be assigned to several areas:

Oxidative Stress

The MIND study [2] is designed as a three-year, multicentre randomised controlled trial and tests the effect of the MIND diet on cognitive function in 604 persons at Alzheimer risk. Men and women aged 65 to 84 years were included; randomisation was to a MIND diet with mild calorie restriction or the usual diet with mild calorie restriction. Cognitive testing, medical history, blood pressure, anthropometric measurements and blood and urine samples are planned at baseline and in follow-up visits; MRI examinations are performed in approximately half of the participants at the beginning and at the end. Special features noted in the protocol include a dietary pattern rather than a single nutrient, the provision of central foods (extra-virgin olive oil, blueberries, nuts) and MRI imaging.

The review article by [36] classifies physical activity and nutrition as lifestyle interventions for dementia-risk reduction and compares strategies of Western and Asian countries. In Western countries, structured programmes such as the Mediterranean diet and the MIND diet are in the foreground, whereas in Asian countries traditional mind-body practices such as Tai Chi and culturally anchored, antioxidant- and polyphenol-rich dietary patterns are included. The work emphasises the need for culturally adapted public-health strategies and individualised approaches in mild cognitive impairment and dementia prevention.

It remains open which of the markers provided for in the protocol actually map the underlying antioxidative and inflammatory pathways.

Cognition and Psyche

The randomised controlled trial by [11] examined a calorie-reduced modified MIND diet versus a calorie-reduced standard diet in 40 overweight women (mean BMI 32±4,31 kg/m², mean age 48±5,38 years). The primary outcome was the change in cognitive performance via a comprehensive neuropsychological test battery; secondarily, brain structure was quantified by voxel-based morphometry; measurements were taken at baseline and after 3 months. 37 participants completed the study (MIND 22, control 15). In the MIND arm, working memory +1,37 (95 % CI 0,79, 1,95), verbal recognition +4,85 (95 % CI 3,30, 6,40) and attention +3,75 (95 % CI 2,43, 5,07) improved more than in the control group (ps<0,05); on MRI the surface area of the inferior frontal gyrus increased in the MIND group.

The analysis of [4] examined, in 604 randomised adults aged 65 to 85 years who were overweight or obese (mean age 70,4 years, 65,5 % women, BMI 33,9 kg/m²), which characteristics modify the effect of the MIND diet on the annual change in a global cognition score from 12 neurocognitive tests. BMI was the only significant modifier (p=0,009); only in persons with BMI ≥35 kg/m² (n=213) was the MIND group associated with higher cognitive values of 0,040 (standard error 0,017, p=0,018) standardised units per year compared with the control group.

In 44 women with type 2 diabetes and insomnia aged 30 to 65 years, [13] compared a calorie-reduced MIND diet (n=22) with a calorie-reduced diet (n=22) over 12 weeks. The MIND group showed a significant decrease in waist circumference as well as a significant improvement in sleep quality, depression and anxiety compared with the control group; additionally, cortisol decreased and BDNF increased significantly.

Among the observational studies, [25] linked a higher MIND score in 960 participants of the Memory and Aging Project over an average of 4,7 years with slower decline of the global cognition score (β=0,0092; P<0,0001) and with each of five cognitive domains; the difference between the highest and lowest tertile corresponded to an age 7,5 years younger. [26] found lower Alzheimer rates for the second (HR=0,65; 95 % CI 0,44, 0,98) and highest tertiles (HR=0,47; 95 % CI 0,26, 0,76) versus the first in 923 participants aged 58 to 98 years over an average of 4,5 years.

[31] evaluated 13 studies (9 cohorts, 3 cross-sectional studies, 1 RCT) and reports that adherence to the MIND diet was positively associated with individual cognitive domains and global cognition in 78 % of the studies and that the MIND diet was superior to other plant-rich diets. [33] included 40 articles with 32 independent cohorts: higher MIND adherence was protective against dementia in 7 of 10 cohorts, positive for global cognition in 3 of 4 cohorts and for episodic memory in 4 of 6; for cognitive decline only 2 of 7 longitudinal cohorts showed positive associations for global and 1 of 6 for episodic deterioration. In a secondary analysis of 494 participants of European ancestry [21] a significant interaction (p=0,002) emerged between the COMT-Val158Met variant and diet assignment for the 3-year change in perceptual speed; Met/Met carriers improved more under the MIND than under the control diet, whereas no difference appeared in Val carriers.

It remains open whether the intervention findings are confirmed in larger, non-obese populations and over longer periods.

Metabolism

The randomised controlled trial [16] examined a hypocaloric modified MIND diet versus a hypocaloric control diet over three months in 37 healthy women (mean age 48±5,38 years, BMI 32±0,69 kg/m²). In the MIND arm a greater reduction was found in weight (P<0,0001), BMI (P<0,0001), body fat percentage (P=0,03), waist circumference (P=0,01) and leptin concentration (P=0,03); in addition ghrelin (P=0,002) and GLP-1 (P=0,01) rose significantly. Measurements were taken at baseline and after three months.

It remains open whether the metabolic effects appear independently of calorie restriction and whether the changes in hunger hormones persist in the longer term.

Inflammatory Processes

The cross-sectional analysis [6] examined the association between dietary patterns and cognition in 967 participants of the UK Multiple Sclerosis Register. The aMED and MIND scores were derived from a 130-item EPIC-Norfolk questionnaire; cognition was captured with the MS-specific Cognitron-MS battery of 13 tasks as global cognition (G-factor) and four domains. Cognitive results were standardised as deviation-from-expected scores; the linear models were adjusted for total energy intake, MS phenotype, disease duration since diagnosis and current disease-modifying therapy.

The systematic review [35] screened 491 studies and included 23 that examined the association of the MIND diet with cardiometabolic diseases and their risk factors in adults. Across the various study designs the MIND diet was generally associated with improvement in anthropometric measures and further cardiometabolic endpoints such as blood pressure, glycaemic control, lipid profile and inflammation.

It remains open whether the observed associations are causal and whether the MIND diet directly alters inflammatory markers.

Gut and Microbiome

The two replicated pilot studies MINDICOMS and MINDICOMS II [24] are designed as two-arm randomised controlled trials and each enrol 60 patients aged 35 to 70 years with acute ischaemic stroke and signs of newly occurring cognitive impairment without dementia. The MIND diet was adapted for the Chinese population and recommends eleven food groups while simultaneously restricting four groups. During the 26-week intervention phase the control group receives standard care plus weekly health-education messages.

It remains open whether the MIND intervention improves cognition after stroke and whether the results reproduce across the two replication waves.

Heart and Circulation

Study [30] examined the association of the MIND diet with dementia risk in three prospective studies and a meta-analysis. The MIND score ranged from 0 to 15, with a higher value indicating stronger adherence.

It remains open whether the association is causal and which mechanisms mediate the relationship between MIND diet and dementia risk.

Overall Picture

Across the areas two strands contribute: on the one hand the large observational cohorts that consistently link higher MIND adherence with better global cognition, slower decline and lower dementia risk [25][26][27][30], on the other hand randomised intervention studies in smaller, often metabolically defined populations that examine cognitive and psychological endpoints over 8 to 12 weeks [11][13][17]. The largest randomised trial, the three-year MIND study in 604 persons at Alzheimer risk [2][4], shows benefit only in the subgroup with BMI ≥35 kg/m².

The systematic reviews paint a mixed picture: while [31] sees the MIND diet as superior to other plant-rich diets, [33] finds protective effects on dementia in 7 of 10 cohorts but only weak evidence for cognitive decline. Genetic secondary analyses [21][5] point to a role of COMT and APOE. What stands at the beginning across all areas: independent replications of the intervention findings in larger, non-obese populations and longer follow-ups.

3. How Robust the Research Is

Of the human studies the clear majority are observational: 112 observational stand against 31 controlled studies, plus 71 basic-research works, 11 review and mechanism papers and two animal studies. Within the controlled human studies cognition dominates clearly; metabolism, safety, cardiovascular, antioxidant questions and fatigue follow with only a few studies each, gut, oncology and immune system are represented by single investigations. The thematic focus therefore lies on cognitive endpoints, while cardiovascular and metabolic topics are covered mainly via review articles.

The methodological strength of the field lies in long-term cohorts from several countries; the systematic reviews from 2022, 2023 and 2024 collate them. The weakness lies in the design imbalance: cohorts show associations but do not separate whether nutrition shapes cognition or whether health-conscious people eat differently and therefore perform better. In addition, several highly cited works belong to the same study consortium — rationale and baseline characteristics, the cognitive test battery, the carotenoid evaluation, the effect modifiers and the genetic resource paper all stem from the same randomised trial. Such publications are valuable but not independent confirmations. Several of the more recent works are feasibility studies or study protocols.

4. What Is Frequently Claimed — and What the Data Support

5. The Most Robust Studies

Ordered by strength of evidence, not by prominence: review articles and studies with many participants first. The complete evaluation comprises considerably more works; the most robust are listed here.

Controlled Human Studies

• 1 Effects of the MIND Diet on the Cognitive Function of Older Adults: A Systematic Review (2025) — review article, 17,201 participants
• 2 Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: Rationale, design and baseline characteristics of a randomized control … (2021) — 604 participants
• 3 Properties of the Cognitive Function Battery for the MIND Diet Intervention to Prevent Alzheimer's Disease (2022) — 604 participants
• 4 Effect modifiers of the MIND diet for cognition in older adults: The MIND diet trial (2025) — 604 participants
• 5 Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Trial: Genetic Resource for Precision Nutrition (2025) — 604 participants
• 6 Mediterranean and MIND Dietary Patterns and Cognitive Performance in Multiple Sclerosis: A Cross-Sectional Analysis of the UK Multiple Sclerosis … (2025) — 967 participants
• 7 Adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and longitudinal changes in global cognition: a post hoc … (2026) — 590 participants
• 8 Dietary intervention and cognition across Alzheimer's disease biomarker levels: The MIND clinical trial (2026) — 2,021 participants
• 9 Rationale and study protocol for a randomized controlled MIND diet feeding trial for breast cancer-related cognitive impairment (2026) — 200 participants
• 10 Association between adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) diet and cerebrospinal fluid Alzheimer's … (2026) — 250 participants
• 11 Effect of MIND diet intervention on cognitive performance and brain structure in healthy obese women: a randomized controlled trial (2022) — 40 participants
• Higher circulating α-carotene was associated with better cognitive function: an evaluation among the MIND trial participants (2021)
• 12 The effect of MIND diet on sleep status, mental health, and serum level of BDNF in overweight/obese diabetic women with insomnia: a randomized … (2025) — 22 participants
• 13 Aerobic Exercise with Mediterranean-DASH Intervention for Neurodegenerative Delay Diet Promotes Brain Cells' Longevity despite Sex Hormone Deficiency … (2022)
• The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol … (2024)
• 14 The Effect of Short-term Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) Diet on Hunger Hormones, Anthropometric Parameters, and … (2022)
• 15 The effects of MIND diet on depression, anxiety, quality of life and metabolic and hormonal status in obese or overweight women with polycystic ovary … (2024) — 52 participants
• 16 The effects of MIND diet and propolis supplementation on metabolic syndrome: A randomized controlled clinical trial (2024)
• 17 The MIND diet, cognitive function, and well-being among healthy adults at midlife: a randomised feasibility trial (2025) — 15 participants
• 18 Effects of MIND diet and propolis supplementation on metabolic syndrome indices and cognitive function among patients with metabolic syndrome in … (2024)
• 19 Genetic Variation in Response to the Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND): A Randomized Controlled Trial (2026)
• Nutrition Effects on Brain Outcomes and Recovery in Stroke after Hospitalization (NOURISH): Randomized controlled trial protocol and rationale (2025)
• 20 Effect of MIND Diet Intervention on Cognitive Performance and Brain Structure in Healthy Obese Women: A Randomized Controlled Trial (2020) — 40 participants
• 21 Mediterranean-DASH Intervention for Neurodegenerative Delay Diet to Improve Cognitive Function in Mild Stroke Patients: Rationale and Design of Two … (2026) — 60 participants

6. Summary

In humans, two strands stand out: large observational cohorts that consistently link higher MIND adherence with better global cognition, slower decline and lower dementia risk, and randomised intervention studies in smaller, often metabolically defined populations that examine cognitive, mental and metabolic endpoints over 8 to 12 weeks. The three-year MIND study in 604 people at risk of Alzheimer’s is the largest randomised trial; it shows a cognitive benefit only in those with BMI ≥35 kg/m².

Hypothesis The intervention findings could present differently in larger, non-obese populations and over longer periods, because the randomised trials conducted so far have mostly examined small, metabolically defined groups over short periods. Genetic secondary analyses point to a role for COMT and APOE; an Australian longitudinal cohort reported an association for the MIND diet but not for the Mediterranean diet, which argues against arbitrary interchangeability of the dietary patterns.

What remains to be clarified is whether the intervention findings can be independently replicated in larger, non-obese populations and over longer follow-up periods. For the inflammatory processes it is open whether the observed associations are causal and whether the MIND diet directly alters inflammatory markers. For the replicated pilot studies MINDICOMS and MINDICOMS II it remains to be examined whether the MIND intervention improves cognition after stroke and whether the results reproduce across the two replication waves. Finally, it is open which of the markers specified in the protocol actually map the underlying antioxidative and inflammatory pathways.

7. What Remains Open

• Independent replication: Which randomised trial outside the existing study network confirms the cognitive effect in healthy older adults?
• Adherence: From what degree of closeness to the recommended diet does a difference appear, and how stable does this score remain over the years?
• Combinations: What proportion of the observed effect is attributable to the dietary pattern when exercise, sleep or further measures are altered concomitantly?